Virmani R, Kolodgie FD, Burke AP et al (2005) Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 25:2054–2061

CAS  PubMed  Google Scholar 

Collet JP, Thiele H, Barbato E et al (2021) 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 42:1289–1367

PubMed  Google Scholar 

Saito Y, Kobayashi Y (2024) Advances in technology and technique in percutaneous coronary intervention: a clinical review. Intern Med. https://doi.org/10.2169/internalmedicine.4505-4524

Article  PubMed  PubMed Central  Google Scholar 

Passer JZ, Loftus CM (2018) Postoperative anticoagulation after neurologic surgery. Neurosurg Clin N Am 29:575–583

PubMed  Google Scholar 

Capodanno D, Alfonso F, Levine GN et al (2018) ACC/AHA versus ESC guidelines on dual antiplatelet therapy: JACC guideline comparison. J Am Coll Cardiol 72:2915–2931

PubMed  Google Scholar 

Condello F, Sturla M, Terzi R et al (2021) Walking the line with ticagrelor: meta-analysis comparing the safety and efficacy of ticagrelor monotherapy after a short course of ticagrelor-based dual antiplatelet therapy versus standard therapy in complex percutaneous coronary intervention. J Clin Med 10(23):5506

PubMed  PubMed Central  Google Scholar 

Zito A, Galli M, Biondi-Zoccai G et al (2023) Diagnostic strategies for the assessment of suspected stable coronary artery disease: a systematic review and meta-analysis. Ann Intern Med 176:817–826

PubMed  Google Scholar 

Baber U, Dangas G, Chandrasekhar J et al (2016) Time-dependent associations between actionable bleeding, coronary thrombotic events, and mortality following percutaneous coronary intervention: results from the PARIS registry. JACC Cardiovasc Interv 9:1349–1357

PubMed  Google Scholar 

Urban P, Gregson J, Owen R et al (2021) Assessing the risks of bleeding vs thrombotic events in patients at high bleeding risk after coronary stent implantation: the arc-high bleeding risk trade-off model. JAMA Cardiol 6:410–419

PubMed  Google Scholar 

Généreux P, Giustino G, Witzenbichler B et al (2015) Incidence, predictors, and impact of post-discharge bleeding after percutaneous coronary intervention. J Am Coll Cardiol 66:1036–1045

PubMed  Google Scholar 

Giustino G, Mehran R (2018) Navigating the complexity of percutaneous coronary intervention in patients at high risk for bleeding. EuroIntervention 14:e383–e385

PubMed  Google Scholar 

Costa F, Windecker S, Valgimigli M (2017) Dual antiplatelet therapy duration: reconciling the inconsistencies. Drugs 77:1733–1754

CAS  PubMed  Google Scholar 

Kabil MF, Abo Dena AS, El-Sherbiny IM (2022) Ticagrelor. Profiles Drug Subst Excip Relat Methodol 47:91–111

CAS  PubMed  Google Scholar 

He C, Zeng W, Su Y et al (2021) Microfluidic-based fabrication and characterization of drug-loaded PLGA magnetic microspheres with tunable shell thickness. Drug Deliv 28:692–699

CAS  PubMed  PubMed Central  Google Scholar 

Li T, Chandrashekar A, Beig A et al (2020) Characterization of attributes and in vitro performance of exenatide-loaded PLGA long-acting release microspheres. Eur J Pharm Biopharm 158:401–409

PubMed  Google Scholar 

Torres-Ramos MI, Martín-Marquez MF, Leal-Moya MDC et al (2022) PLGA-TiO2 as a carrier system for drug release. Int J Mol Sci 23:10755

CAS  PubMed  PubMed Central  Google Scholar 

Butreddy A, Gaddam RP, Kommineni N et al (2022) PLGA/PLA-based long-acting injectable depot microspheres in clinical use: production and characterization overview for protein/peptide delivery. Int J Mol Sci 22:8884

Google Scholar 

Sanderson NC, Parker WAE, Storey RF (2021) Ticagrelor: clinical development and future potential. Rev Cardiovasc Med 22:373–394

PubMed  Google Scholar 

Virk HUH, Escobar J, Rodriguez M, Bates ER et al (2023) Dual antiplatelet therapy: a concise review for clinicians. Life (Basel) 13(7):1580

CAS  PubMed  Google Scholar 

Gelbenegger G, Jilma B (2022) Clinical pharmacology of antiplatelet drugs. Expert Rev Clin Pharmacol 15:1177–1197

CAS  PubMed  Google Scholar 

Siller-Matula JM, Krumphuber J, Jilma B (2010) Pharmacokinetic, pharmacodynamic and clinical profile of novel antiplatelet drugs targeting vascular diseases. Br J Pharmacol 159:502–517

CAS  PubMed  Google Scholar 

Varga N, Bélteki R, Juhász Á et al (2023) Core-shell structured plga particles having highly controllable ketoprofen drug release. Pharmaceutics 15(5):1355

CAS  PubMed  PubMed Central  Google Scholar